Pacira Pharmaceuticals (PCRX)

Add to Watchlists
Create an Alert
45.15 -0.30  -0.66% NASDAQ May 26, 20:00 Delayed 2m USD

Pacira Pharmaceuticals EV to EBITDA (TTM)

View 4,000+ financial data types
View Full Chart

Pacira Pharmaceuticals EV to EBITDA (TTM) Chart

Pacira Pharmaceuticals Historical EV to EBITDA (TTM) Data

View and export this data going back to 2011. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 29, 2016 Upgrade
Sept. 28, 2016 Upgrade
Sept. 27, 2016 Upgrade
Sept. 26, 2016 Upgrade
Sept. 23, 2016 Upgrade
Sept. 22, 2016 Upgrade
Sept. 21, 2016 Upgrade
Sept. 20, 2016 Upgrade
Sept. 19, 2016 Upgrade
Sept. 16, 2016 Upgrade
Sept. 15, 2016 Upgrade
Sept. 14, 2016 Upgrade
Sept. 13, 2016 Upgrade
Sept. 12, 2016 Upgrade
Sept. 9, 2016 Upgrade
Sept. 8, 2016 Upgrade
Sept. 7, 2016 Upgrade
Sept. 6, 2016 Upgrade
Sept. 2, 2016 Upgrade
Sept. 1, 2016 Upgrade
Aug. 31, 2016 Upgrade
Aug. 30, 2016 Upgrade
Aug. 29, 2016 Upgrade
Aug. 26, 2016 Upgrade
Aug. 25, 2016 Upgrade
Aug. 24, 2016 Upgrade
Aug. 23, 2016 Upgrade
Aug. 22, 2016 Upgrade
Aug. 19, 2016 Upgrade
Aug. 18, 2016 Upgrade
Aug. 17, 2016 Upgrade
Aug. 16, 2016 Upgrade
Aug. 15, 2016 Upgrade
Aug. 12, 2016 Upgrade
Aug. 11, 2016 Upgrade
Aug. 10, 2016 Upgrade
Aug. 9, 2016 Upgrade
Aug. 8, 2016 Upgrade
Aug. 5, 2016 Upgrade
Aug. 4, 2016 Upgrade
Aug. 3, 2016 Upgrade
Aug. 2, 2016 Upgrade
Aug. 1, 2016 Upgrade
July 29, 2016 Upgrade
July 28, 2016 Upgrade
July 27, 2016 Upgrade
July 26, 2016 Upgrade
July 25, 2016 Upgrade
July 22, 2016 Upgrade
July 21, 2016 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


EV/EBITDA is the enterprise value of a company divided by its earnings before interest, taxes, depreciation and amortization. (EV/EBITDA)

EV/EBITDA answers the question "What is a company being valued per each dollar of EBITDA?" A high (low) EV/EBITDA mean the company is potentially overvalued (undervalued).

EV/Financial Metrics are often used by analysts to quickly look at a company's valuation multiples. All things being equal, the lower this ratio is, the better.

Other similar metrics include :
EV/Revenues: How much is each dollar of revenues worth to investors?
EV/EBIT : Or each dollar of EBIT?
EV/Free Cash Flow : Or each dollar of FCF?

For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
Learn More

View EV to EBITDA (TTM) for PCRX

Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
Start your free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

PCRX EV to EBITDA (TTM) Benchmarks

Amicus Therapeutics Upgrade
Akorn Upgrade
The Medicines Upgrade

PCRX EV to EBITDA (TTM) Range, Past 5 Years

Minimum Upgrade Oct 06 2015
Maximum Upgrade Feb 25 2015
Average Upgrade

PCRX EV to EBITDA (TTM) Excel Add-In Codes

  • Metric Code: ev_ebitda
  • Latest data point: =YCP("PCRX", "ev_ebitda")
  • Last 5 data points: =YCS("PCRX", "ev_ebitda", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.